These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

455 related items for PubMed ID: 19332960

  • 1. Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy.
    Oparil S, Weber M.
    Postgrad Med; 2009 Mar; 121(2):25-39. PubMed ID: 19332960
    [Abstract] [Full Text] [Related]

  • 2. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
    Ogawa H, Kim-Mitsuyama S, Jinnouchi T, Matsui K, Arakawa K.
    Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
    [Abstract] [Full Text] [Related]

  • 3. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 4. Optimizing management of hypertension with combination therapy: considerations for the nurse practitioner.
    Roberts ME, Epstein BJ.
    J Cardiovasc Nurs; 2009 Aug; 24(5):380-9. PubMed ID: 19707098
    [Abstract] [Full Text] [Related]

  • 5. The importance of early antihypertensive efficacy: the role of angiotensin II receptor blocker therapy.
    Basile JN, Chrysant S.
    J Hum Hypertens; 2006 Mar; 20(3):169-75. PubMed ID: 16397516
    [Abstract] [Full Text] [Related]

  • 6. Optimization of hypertension management: the role of angiotensin receptor blocker-calcium channel blocker combinations.
    Parati G.
    J Cardiovasc Pharmacol; 2009 May; 53(5):352-8. PubMed ID: 19365281
    [Abstract] [Full Text] [Related]

  • 7. Complementary mechanisms of angiotensin receptor blockers and calcium channel blockers in managing hypertension.
    Neutel JM.
    Postgrad Med; 2009 Mar; 121(2):40-8. PubMed ID: 19332961
    [Abstract] [Full Text] [Related]

  • 8. Renoprotective effect of calcium channel blockers in combination with an angiotensin receptor blocker in elderly patients with hypertension. A randomized crossover trial between benidipine and amlodipine.
    Miyagawa K, Dohi Y, Nakazawa A, Sugiura T, Yamashita S, Sato K, Kimura G.
    Clin Exp Hypertens; 2010 Jan; 32(1):1-7. PubMed ID: 20144066
    [Abstract] [Full Text] [Related]

  • 9. Olmesartan/Amlodipine: combination therapy for the treatment of hypertension [corrected].
    Pimenta E.
    Adv Ther; 2009 Jan; 26(1):1-11. PubMed ID: 19129998
    [Abstract] [Full Text] [Related]

  • 10. The role of fixed-dose combination therapy with drugs that target the renin-angiotensin system in the hypertension paradigm.
    Schmieder RE.
    Clin Exp Hypertens; 2010 Jan; 32(1):35-42. PubMed ID: 20144071
    [Abstract] [Full Text] [Related]

  • 11. Rationale, study design and implementation of the COLM study: the combination of OLMesartan and calcium channel blocker or diuretic in high-risk elderly hypertensive patients.
    Ogihara T, Saruta T, Rakugi H, Shimamoto K, Ito S, Matsuoka H, Horiuchi M, Imaizumi T, Takishita S, Higaki J, Katayama S, Saito I, Shimada K, COLM study investigators.
    Hypertens Res; 2009 Feb; 32(2):163-7. PubMed ID: 19262477
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of fixed-dose combination therapy in the treatment of patients with hypertension: focus on amlodipine/valsartan.
    da Silva PM.
    Clin Drug Investig; 2010 Feb; 30(9):625-41. PubMed ID: 20626210
    [Abstract] [Full Text] [Related]

  • 13. Olmesartan/amlodipine: blood pressure lowering and beyond in special populations.
    Erdine S.
    Ther Adv Cardiovasc Dis; 2012 Feb; 6(1):31-44. PubMed ID: 22222315
    [Abstract] [Full Text] [Related]

  • 14. Cost-utility analysis of antihypertensive combination therapy in Japan by a Monte Carlo simulation model.
    Saito I, Kobayashi M, Matsushita Y, Mori A, Kawasugi K, Saruta T.
    Hypertens Res; 2008 Jul; 31(7):1373-83. PubMed ID: 18957808
    [Abstract] [Full Text] [Related]

  • 15. Treatment of essential hypertension with calcium channel blockers: what is the place of lercanidipine?
    Burnier M, Pruijm M, Wuerzner G.
    Expert Opin Drug Metab Toxicol; 2009 Aug; 5(8):981-7. PubMed ID: 19619074
    [Abstract] [Full Text] [Related]

  • 16. Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system.
    de la Sierra A.
    J Hum Hypertens; 2009 Aug; 23(8):503-11. PubMed ID: 19148104
    [Abstract] [Full Text] [Related]

  • 17. Role of combination therapy in the treatment of hypertension: focus on valsartan plus amlodipine.
    Ferri C, Croce G, Desideri G.
    Adv Ther; 2008 Apr; 25(4):300-20. PubMed ID: 18449492
    [Abstract] [Full Text] [Related]

  • 18. High-dose monotherapy vs low-dose combination therapy of calcium channel blockers and angiotensin receptor blockers in mild to moderate hypertension.
    Andreadis EA, Tsourous GI, Marakomichelakis GE, Katsanou PM, Fotia ME, Vassilopoulos CV, Diamantopoulos EJ.
    J Hum Hypertens; 2005 Jun; 19(6):491-6. PubMed ID: 15759025
    [Abstract] [Full Text] [Related]

  • 19. Efficacy and safety of angiotensin II type 1 receptor blocker/calcium channel blocker combination therapy for hypertension: focus on a single-pill fixed-dose combination of valsartan and amlodipine.
    Miura S, Saku K.
    J Int Med Res; 2012 Jun; 40(1):1-9. PubMed ID: 22429340
    [Abstract] [Full Text] [Related]

  • 20. Differential impact of angiotensin receptor blockers and calcium channel blockers on arterial stiffness.
    Andreadis EA, Sfakianakis ME, Tsourous GI, Georgiopoulos DX, Fragouli EG, Katsanou PM, Tavoularis EI, Skarlatou MG, Marakomichelakis GE, Ifanti GK, Diamantopoulos EJ.
    Int Angiol; 2010 Jun; 29(3):266-72. PubMed ID: 20502415
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.